Showing results (51-60 of 789) with videos related to
Sort By:
Pageof 79
Clinical Lymphoma, Myeloma & Leukemia|February 12, 2022
Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple MyelomaMeletios-Athanasios Dimopoulos, Paul Richardson, Sagar LonialClinical Advances in Hematology & Oncology : H&O|March 19, 2021
Antibody treatment in multiple myelomaKathryn T Maples, Catherine Johnson, Sagar LonialClinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple MyelomaPaola Neri, Nizar J Bahlis, Sagar LonialCancer|August 10, 2021
"I took the road less traveled, and that has made all the difference": Making a case for high-dose therapy and autologous stem cell transplantation in elderly patients with newly diagnosed multiple myelomaAjay K Nooka, Nisha S Joseph, Sagar LonialClinical Lymphoma & Myeloma|November 21, 2007
Maintenance therapy in lymphomaRonald Mihelic, Jonathan Kaufman, Sagar Lonial, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2011
Treatment options for relapsed and refractory multiple myelomaSagar Lonial, Constantine S Mitsiades, Paul G RichardsonThe Lancet. Haematology|February 3, 2022
Risk stratified management approaches for smouldering multiple myeloma: clinical research becomes clinical practiceSagar Lonial, S Vincent Rajkumar, Maria Victoria MateosBiologics : Targets & Therapy|February 7, 2013
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomibAjay Nooka, Charise Gleason, Daniela Casbourne, et al.Clinical Advances in Hematology & Oncology : H&O|May 5, 2023
Novel approaches to the treatment of multiple myelomaKathryn T Maples, Sara A Scott, Sagar LonialExpert Opinion on Biological Therapy|October 25, 2013
Elotuzumab: a novel anti-CS1 monoclonal antibody for the treatment of multiple myelomaSagar Lonial, Jonathan Kaufman, Jacob Laubach, et al.Pageof 79